Sort
17,828 grants matching “crispr”
A somatic hypermutation defective UNG mutant in antibody deficiency through destabilization of RPA interaction.
$81,000Kevin Michael McBride · University Of Tx Md Anderson Can Ctr · R03 · FY2024 · AI
NPEPPS is a novel and druggable determinant of chemotherapy resistance in bladder cancer
$80,996Dan Theodorescu · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Hereditary Genetics of Hepatocellular Carcinoma
$80,995Kirk J Wangensteen · Mayo Clinic Rochester · R37 · FY2022 · CA
Cancer and Context
$80,944Ian G Macara · Vanderbilt University · R35 · FY2018 · CA
Gene Targeting & Transgenic Shared Resource
$80,797Eugene Yu · Roswell Park Cancer Institute Corp · P30 · FY2022 · CA
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
$80,750David P Toczyski · University Of California, San Francisco · R03 · FY2022 · CA
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
$80,750David P Toczyski · University Of California, San Francisco · R03 · FY2023 · CA
Engineered precancerous cells and tissues for discovery of lung cancer drivers
$80,750Kwon-Sik Park · University Of Virginia · R03 · FY2018 · CA
Investigating the Role of Mutagenic DNA Repair during the Persistence of Cancer Cells
$80,702Megan Elizabeth Kelley · Sloan-Kettering Inst Can Research · F32 · FY2025 · CA
PROJECT 1
$80,536Reuben S Harris · University Of Texas Hlth Science Center · P01 · FY2023 · CA
Engineered precancerous cells and tissues for discovery of lung cancer drivers
$80,521Kwon-Sik Park · University Of Virginia · R03 · FY2017 · CA
Defining and targeting the molecular vulnerabilities of the PAX3-FOXO1 protein in rhabdomyosarcoma
$80,500Corinne Mary Linardic · Duke University · U54 · FY2020 · CA
Mediators of PCSK9 Secretion as Targets Against Atherosclerosis
$80,335John S Chorba · University Of California, San Francisco · R03 · FY2019 · HL
Ethical, Legal, Social and Governance Issues in Non-Traditional Genetics and Genomics
$80,333Maxwell J Mehlman · Case Western Reserve University · R03 · FY2020 · HG
High Frequency of CHD1 Loss in BRCA2- Deficient African American Prostate Tumors Drives Tumor Formation by Suppressing Replication Stress
$80,332Zoltan Szallasi · Dana-Farber Cancer Inst · U54 · FY2021 · CA
Investigating Neisseria gonorrhoeae chromosomal replication dynamics
$80,224Iryna Boiko · Northwestern University At Chicago · F32 · FY2025 · AI
Regulation of IGF-1R in acute and chronic thyroid eye disease
$80,224Sarah Cheng · University Of California, San Diego · F32 · FY2025 · EY
Toward the Precision Diagnosis and Prevention of Acquired and Congenital Long QT Arrhythmias
$80,224Michael Bon-Hao Liu · Stanford University · F32 · FY2025 · HL
TOOLKIT Core
$80,174Calvin J Kuo · Stanford University · U54 · FY2022 · CA
Mediators of PCSK9 Secretion as Targets Against Atherosclerosis
$80,042John S Chorba · University Of California, San Francisco · R03 · FY2018 · HL
Ethical, Legal, Social and Governance Issues in Non-Traditional Genetics and Genomics
$80,000Maxwell J Mehlman · Case Western Reserve University · R03 · FY2019 · HG
ANTI-HIV GENE THERAPY VECTORS
$80,000Anjali Joshi · Texas Tech University Health Sciences Center At El Paso · R03 · FY2019 · AI
WDR5 WIN Site Inhibition in Colorectal Cancer
$79,988Brian C Grieb · Vanderbilt University Medical Center · F32 · FY2022 · CA
Programmable Microvesicles for Intracellular Macromolecule Delivery
$79,828Xuedong Liu · University Of Colorado · R01 · FY2023 · GM
Programmable Microvesicles for Intracellular Macromolecule Delivery
$79,828Xuedong Liu · University Of Colorado · R01 · FY2024 · GM